Related Experiment Video
Updated: Jan 8, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
Technology and Dementia Preconference
Jonas Marquardt1, Niklas Vockert1, Niklas Behrenbruch1,2
1German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
Summary
Smartphone navigation training improved spatial abilities in older adults. Enhanced wayfinding efficiency linked to better hippocampal vascularization and lower Alzheimer's disease biomarkers.
Area of Science:
- Neuroscience
- Gerontology
- Cognitive Psychology
Background:
- Alzheimer's Disease (AD) pathology impacts the medial temporal lobe (MTL) early, affecting spatial navigation.
- Spatial navigation deficits are an early cognitive symptom of AD.
- Targeted behavioral interventions may mitigate these navigation impairments.
Purpose of the Study:
- To assess a novel smartphone-assisted real-world wayfinding training for healthy older adults.
- To evaluate improvements in spatial abilities after the training.
- To explore associations between navigation performance, hippocampal vascularization, and AD biomarkers.
Main Methods:
- 38 healthy older adults (62-84 years) underwent a 3-week smartphone navigation training ('Explore' app).
- GPS data recorded during real-world navigation tasks; pre/post fMRI, virtual pointing tasks, and VWLT administered.
- AD biomarkers (plasma Abeta1-42/1-40, Ptau217) and hippocampal vascularization (7T angiography) were assessed.
Main Results:
- Navigation training significantly improved performance in pointing and map drawing tasks (p <.001).
- Mobile wayfinding data showed significant training benefits (p ≤.017).
- Improved wayfinding efficiency correlated with reduced hippocampal vessel distance (r=.44, p=.012); higher pTau217 correlated with fewer orientation stops (r=-.38, p=.019).
Conclusions:
- Remotely administered real-world wayfinding training enhances spatial abilities and navigation in older adults.
- Hippocampal vascularization may positively influence wayfinding efficiency.
- Elevated pTau217 levels were associated with specific navigation behaviors, suggesting a link to AD pathology.
Related Concept Videos
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

